Search

(GLOBE NEWSWIRE via COMTEX) -- Company has completed the required preclinical studies and will seek regulatory approval to dose volunteers in Belgium by the end of the year WEST LAFAYETTE, [...]

Solicitation (original): manufacturing and nonclinical studies support for the development of therapeutic biotechnology products (biologics) for neurological related disorders the national institutes of neurological disorders and stroke (ninds) has a [...]

SAN FRANCISCO: Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application and granted Fast Track designation [...]

SAN DIEGO: Oncolytics Biotech(r) Inc., a leading clinical-stage company specializing in immunotherapeutics for oncology, announced the dosing of the first patient in the new GOBLET study cohort evaluating pelareorep and [...]

PALM BEACH: FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common [...]

Portland, OR June 22, 2024 --(PR.com)-- MAIA Biotechnology, a leader in targeted therapy and immuno-oncology, has partnered with Cromos Pharma, a US-based international clinical research organization, to continue making significant [...]

Demonstrating pelareorep's synergy with modified FOLFIRINOX +/- atezolizumab in pancreatic cancer could expand the number of patients it may benefit Funding for the study comes from the US$5 million Therapeutic [...]

* New science for cancer therapy drives powerful value proposition * Exceptional measures of efficacy by lead drug THIO in Phase 2 clinical trial * Funding of more than $12M [...]

VANCOUVER, BC: USA News Group has issued the following news release: USA News Group - Hope is rising in the fight against one of the deadliest cancers in the world, [...]

USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, May 15, 2024 /PRNewswire/ -- https://usanewsgroup.com/2023/10/02/the-most-undervalued-oncolytics-company-on-the-nasdaq/ -- Hope is rising in the fight against one of the [...]

PISCATAWAY: GenScript Biotech Corporation has issued the following news release: GenScript Biotech Corporation, a global leader in life science research tools and services, has today announced the expansion of its [...]

GenScript continues to build on its fast and dependable in vitro transcription RNA synthesis service, offering a new self-amplifying RNA format that enhances the potency and efficacy of vaccines, immunotherapies, [...]

SAN FRANCISCO: Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., the leader in enabling the development and supply of better treatments for patients worldwide, entered [...]

Presented data which, along with ongoing IND-enabling studies, demonstrate efficacy and pharmacology of ABO-101 in non-human primates (NHPs), supporting continued development as a potential novel gene editing therapy for patients [...]

CHUNGCHEONGBUK-DO ANIMAL HYGIENE TESTING LABORATORY, South Korea has invited tenders for Purchase of Biotechnology Research Commercialization Products (In Vitro Fertilized Eggs). Tender Notice No: 20240219809-00 Deadline: February 21, 2024 Copyright [...]

CAMBRIDGE: Arbor Biotechnologies(r), a biotechnology company discovering and developing the next generation of genetic medicines, today announced four upcoming presentations at the 2024 American Society of Gene and Cell Therapy [...]

- Oral and poster presentations showcase data demonstrating pipeline progress and continued advancement of Arbor's pipeline programs toward the clinic - Oral presentation with data validating aspects of Arbor's approach [...]

NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces today that [...]

PharmAla Biotech (OTCQB:MDXXF) on Tuesday announced that it entered into a binding sales agreement with Numinus Wellness (OTCQX:NUMIF) to provide its GMP LaNeo MDMA for a prospective clinical [...]

KOTA KINABALU: European Wellness announces a groundbreaking collaboration with the Sabah state government, aimed at positioning Sabah as a premier destination for medical wellness tourism on the global stage. Chief [...]

KOTA KINABALU, Malaysia, March 14, 2024 /PRNewswire/ -- European Wellness, a leading name in health and wellness, announces a groundbreaking collaboration with the Sabah state government, aimed at positioning Sabah [...]

DUBLIN, March 11, 2024 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5942096/cell-cryopreservation-market-forecasts?utm_source=CI&utm_medium=PressRelease&utm_code=wt3r52&utm_campaign=1943957+-+Cell+Cryopreservation+Market+Report+2024-2029%2c+with+Profiles+of+Key+Players+Irvine+Scientific%2c+Biogenuix%2c+Cryo-Cell%2c+Sartorius%2c+Sigma-Aldrich%2c+Cytiva%2c+AMSBIO+and+Transgen+Biotech&utm_exec=carimspi report has been added toResearchAndMarkets.com's offering. The cell cryopreservation market is estimated to grow at a CAGR of 22.35% during the forecast [...]

-ATX-01 is the industry's first microRNA therapeutic to be evaluated for DM1 and the first program from ARTHEX's pipeline to enter the clinic -- -First patient expected to be enrolled [...]

PITTSBURGH: Krystal Biotech, Inc. , a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation for inhaled KB707 for the treatment of [...]

? FDA clears IND and Phase 1 (KYANITE-1) clinical trial expected to be initiated in 1H 2024 PITTSBURGH, Feb. 13, 2024 (GLOBE NEWSWIRE) -- https://www.krystalbio.com (the 'Company') (NASDAQ: KRYS), a [...]

DUBLIN: Research and Markets has issued the following news release: The 'Neuromodulation Devices Market Report 2024-2034' has been added to ResearchAndMarkets.com's offering. Revenue for the neuromodulation devices market is forecast [...]

2024 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- GenScript Biotech Corporation, a global leader in life science research tools and services, has announced [...]

2024 MAY 15 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- USA News Group - An alarming trend is happening around the world, where tens of [...]

Spain based Genycell Biotech Espana S.L.U has secured contract from Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos for All other non-therapeutic products - Comprehensive NGS solution supply [...]

NEW YORK: The Rootist has issued the following news release: From established beauty entrepreneur David C. Chung, founder of the beloved skincare brand Farmacy Beauty, comes The Rootist, a breakthrough [...]

The Newest Innovation from Esteemed Entrepreneur David C. Chung, The Rootist, Debuts Exclusively at Sephora NEW YORK, Jan. 10, 2024 /PRNewswire/ -- From established beauty entrepreneur David C. Chung, founder [...]

JUPITER, Fla.--(BUSINESS WIRE)--Jan 8, 2024-- Cognigenics, Inc., is pioneering next-generation therapeutic approaches to treating mental health, neuropsychiatric and neurodegenerative disorders. Our proprietary platform technology employs genetic neuroengineering to accurately and [...]

JUPITER, Fla. -- Cognigenics, Inc., is pioneering next-generation therapeutic approaches to treating mental health, neuropsychiatric and neurodegenerative disorders. Our proprietary platform technology employs genetic neuroengineering to accurately and noninvasively target [...]

Partnership brings together two leaders in next-generation genetic medicines to engineer, co-develop and co-commercialize (50:50 profit share) AAV-delivered CRISPR/Cas-based therapeutics for up to six product candidates in CNS Initial product [...]

EMERYVILLE: 4D Molecular Therapeutics, a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, and Arbor Biotechnologies, Inc., a next-generation [...]

NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating therapeutic cancer vaccines based on its T-win[sup.(R)] platform, announced today [...]

NEW YORK: IO Biotech has issued the following press release: IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating therapeutic cancer vaccines based on its T-win(r) platform, [...]

- OTC Deficiency Gene Insertion Program, ECUR-506, Receives Clearance from Australian Therapeutic Goods Administration for Phase 1/2 Study DURHAM, N.C. -- Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing [...]

AMSTERDAM: Scenic Biotech has issued the following news release: Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, today announced positive preclinical data [...]

Union Minister of Health & Family Welfare Dr Mansukh Mandaviya virtually addresses Vibrant Gujarat Pre-Summit on Biotechnology 'India's BioEconomy has grown eight times in the last eight years from $10 [...]

NEW DELHI, India -- The following information was released by the Government of India: India's 'Bio-Economy' has grown eight times in the last eight years from $10 billion to $80 [...]